322 related articles for article (PubMed ID: 31859047)
1. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis.
Cohen JN; Bowman S; Laszik ZG; North JP
J Am Acad Dermatol; 2020 Feb; 82(2):430-439. PubMed ID: 31859047
[TBL] [Abstract][Full Text] [Related]
2. Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.
Stoffel E; Maier H; Riedl E; Brüggen MC; Reininger B; Schaschinger M; Bangert C; Guenova E; Stingl G; Brunner PM
Br J Dermatol; 2018 May; 178(5):1151-1162. PubMed ID: 29143979
[TBL] [Abstract][Full Text] [Related]
3. T-helper immune phenotype may underlie 'paradoxical' tumour necrosis factor-α inhibitor therapy-related psoriasiform dermatitis.
Moy AP; Murali M; Kroshinsky D; Horn TD; Nazarian RM
Clin Exp Dermatol; 2018 Jan; 43(1):19-26. PubMed ID: 28940220
[TBL] [Abstract][Full Text] [Related]
4. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
[TBL] [Abstract][Full Text] [Related]
5. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
[TBL] [Abstract][Full Text] [Related]
6. TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists.
Deubelbeiss C; Kolios AGA; Anzengruber F; French LE; Yawalkar N; Kempf W; Kerl K; Meier B; Navarini AA
J Cutan Pathol; 2018 Jan; 45(1):23-28. PubMed ID: 29023827
[TBL] [Abstract][Full Text] [Related]
7. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
8. Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?
Megna M; Caiazzo G; Parisi M; Ruggiero A; Capasso G; Mascolo M; Russo D; Gallo L; Fabbrocini G; Napolitano M; Patruno C
Clin Exp Dermatol; 2022 May; 47(5):918-925. PubMed ID: 34862807
[TBL] [Abstract][Full Text] [Related]
9. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
10. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
[TBL] [Abstract][Full Text] [Related]
11. Mutual antagonism of T cells causing psoriasis and atopic eczema.
Eyerich S; Onken AT; Weidinger S; Franke A; Nasorri F; Pennino D; Grosber M; Pfab F; Schmidt-Weber CB; Mempel M; Hein R; Ring J; Cavani A; Eyerich K
N Engl J Med; 2011 Jul; 365(3):231-8. PubMed ID: 21774711
[No Abstract] [Full Text] [Related]
12. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.
Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K
Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319
[TBL] [Abstract][Full Text] [Related]
14. Possible pathogenic role of Th17 cells for atopic dermatitis.
Koga C; Kabashima K; Shiraishi N; Kobayashi M; Tokura Y
J Invest Dermatol; 2008 Nov; 128(11):2625-2630. PubMed ID: 18432274
[TBL] [Abstract][Full Text] [Related]
15. Differential histopathological and immunohistochemical findings between palmar psoriasis and chronic hand eczema.
An MK; Yoon JH; Park EJ; Park HR; Kim KJ; Kim KH
Eur J Dermatol; 2020 Dec; 30(6):710-715. PubMed ID: 33155552
[TBL] [Abstract][Full Text] [Related]
16. Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.
Darrigade AS; Milpied B; Truchetet ME; Schaeverbeke T; Laharie D; Zerbib F; Beylot-Barry M; Jouary T; Taïeb A; Ezzedine K; Seneschal J
Acta Derm Venereol; 2017 Jun; 97(6):731-734. PubMed ID: 28218339
[TBL] [Abstract][Full Text] [Related]
17. A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesis.
Teraki Y; Tanaka S; Hitomi K; Izaki S
Br J Dermatol; 2010 Dec; 163(6):1347-51. PubMed ID: 20731653
[No Abstract] [Full Text] [Related]
18. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
19. [Psoriasis or atopic eczema: skin-infiltrating effector memory T cells make the difference].
Homey B
Hautarzt; 2012 Jan; 63(1):52. PubMed ID: 22212158
[No Abstract] [Full Text] [Related]
20. Characterization of T-Helper Immune Phenotype in Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Endorses a Delayed-Type Hypersensitivity Reaction.
Chaudet KM; Russell-Goldman E; Horn TD; Schuler AM; Chan MP; Nazarian RM
Am J Dermatopathol; 2024 Feb; 46(2):71-78. PubMed ID: 38133537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
